Technical
Channels

Drug Discovery

Drug Development

Drug Manufacturing

Drug Delivery

Clinical Trials

Regulatory and Legal

Alliances and Mergers

QA/QC and Compliance

Pharmaceutical Processing and Packaging

Change text size [+] [-]

Millipore Introduces Fluorescing Stem Cell Lines

Monday, September 07, 2009
 Email This |  Printer Friendly

Millipore has announced the introduction of three MilliTrace stem cell lines, which express Green Fluorescent Protein (GFP) under the control of various embryonic and neural stem cell markers. Due to their brilliant green glow, these cells offer scientists a quick, non-invasive way to monitor the behavior of specific stem cell populations as they proliferate, migrate, and differentiate into various lineages.

The cell lines feature GFP reporters under the control of nanog (mouse embryonic stem cells) or nestin and Sox-2 (human neural stem cells) transcription factors. The loss of these stem cell markers during differentiation causes down-regulation of the GFP, making it easy to spot cells that have not differentiated.

Following transfection with humanized mulleri GFP, every cell line is validated for high levels of GFP expression, stem cell marker expression, and multipotency. The cells are also supplied with an optimized expansion medium to help maintain expression of the transgene.


Share this:   Del.icio.us | 
Ask the Expert

What technologies and/or practices can Asian pharma manufacturers adopt today, to ensure quality in their products?

Digital Edition



Singapore's Preclinical R&D industry should differentiate itself in Asia by competing on quality rather than on price.
Yes
No
View results


ABOUT PHARMA ASIA | FREE SUBSCRIPTION | CONTACT US

© 2010 Ten Alps Communications Asia. All rights reserved.
Use of this Web site is subjected to its Terms and Conditions of Use. View our Privacy Policy